Elisha Singer, M.D.

  1. Dermatologist
  1. Nattkemper LA, Martinez-Escala ME, Gelman AB, Singer EM, Rook AH, Guitart J, Yosipovitch G. Cutaneous T-cell Lymphoma and Pruritus: The Expression of IL-31 and its Receptors in the Skin. Acta Derm Venereol. 2016 Nov 2; 96 (7):894-898
    View PubMed
  2. Cedeno-Laurent F, Singer EM, Wysocka M, Benoit BM, Vittorio CC, Kim EJ, Yosipovitch G, Rook AH. Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities. Clin Immunol. 2015 May; 158 (1):1-7 Epub 2015 Mar 08
    View PubMed
  3. Wysocka M, Kossenkov AV, Benoit BM, Troxel AB, Singer E, Schaffer A, Kim B, Dentchev T, Nagata S, Ise T, Showe LC, Rook AH. CD164 and FCRL3 are highly expressed on CD4+CD26- T cells in Sezary syndrome patients. J Invest Dermatol. 2014 Jan; 134 (1):229-236 Epub 2013 June 21
    View PubMed
  4. Singer EM, Shin DB, Nattkemper LA, Benoit BM, Klein RS, Didigu CA, Loren AW, Dentchev T, Wysocka M, Yosipovitch G, Rook AH. IL-31 is produced by the malignant T-cell population in cutaneous T-Cell lymphoma and correlates with CTCL pruritus. J Invest Dermatol 2013 Dec; 133 (12):2783-2785 Epub 2013 May 22
    View PubMed